SBFM – sunshine biopharma inc. (US:NASDAQ)
Stock Stats
News
Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus [Yahoo! Finance]
Sunshine Biopharma Announces Novel Inhibitor for Sars Coronavirus
Sunshine Biopharma, Inc. (NASDAQ: SBFM) had its "buy" rating re-affirmed by analysts at Aegis. They now have a $15.00 price target on the stock.
Sunshine Biopharma Launches a New Generic Prescription Drug
Sunshine Biopharma Announces Breakthrough Research Results on the Company's K1.1 mRNA Product as a Novel Therapeutic Agent for Human Hepatocellular Carcinoma [Yahoo! Finance]
Form 8-K Sunshine Biopharma Inc. For: Dec 10
Form SC 13G/A Sunshine Biopharma Inc. Filed by: ARMISTICE CAPITAL, LLC
Form 424B4 Sunshine Biopharma Inc.
Form EFFECT Sunshine Biopharma Inc.
Form 8-K Sunshine Biopharma Inc. For: Nov 06
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.